YIDU TECH (02158) has repurchased approximately 53 million Hong Kong dollars over the past 10 days. Citibank has raised its target price to HK$11.

On February 6, YIDU TECH (02158) announced a stock repurchase notification: the company repurchased approximately 1.6 million shares at a price of about HKD 5.63 per share on the same day, with a total cost exceeding HKD 9 million, achieving the tenth consecutive trading day of intensive repurchases, with a cumulative repurchase amount of approximately HKD 53 million. This week, the company's repurchase shows the dual characteristics of "high frequency + high position": on February 3, it ranked among the top three in the daily Hong Kong stock repurchase list with a total of HKD 8.2179 million, with consecutive daily repurchases exceeding HKD 10 million on February 4-5, and on February 6, it continued a steady trend with a investment of over HKD 9 million, with a consistent and sufficient pace of actions, demonstrating the management's conviction of the company's intrinsic value and a clear intention to maintain market value. Institutions also have a positive outlook on YIDU TECH's development prospects. On February 5, Citigroup released a latest research report maintaining a "buy" rating for YIDU TECH and raised its target price to HKD 11, expecting a potential increase of over 96% in the future stock price. Citigroup believes that YIDU TECH's unique advantage lies in its large-scale data processing from top hospitals, with data quality and authority as the cornerstone. This ability to train medical AI models based on high-quality real-world data is the foundation for precise diagnosis and decision-making. Compared to consumer applications that are still in the exploration stage, the business sectors targeting governments and hospitals demonstrate more predictable profit-making capabilities and directly benefit from the increase in hospital AI budgets and national project tenders. Based on its solid business model and clear growth path, Citigroup has raised its financial forecasts for the company, expecting its big data platform revenue to achieve year-on-year growth of 17% and 30% in the fiscal years 2026 and 2027 respectively, and is expected to break even in the fiscal year 2026.